UPDATE: ISI Raises Taubman Centers' PT

According to a research report published this morning, ISI has increased Taubman Centers' TCO PT from $75 to $82. In the report, ISI commented, "Taubman reported 1Q12 FFO of $0.75 which was $0.04 ahead of our estimate and the Street consensus. NOI basically blew past our estimate, beating us by $0.06 while higher-than-expected management expenses of $0.02 partially offset the stronger NOI. We're sure investors will question certain line items in the quarter including: 1) operating expenses were well below expectations, 2) how did the recovery ratio increase 8% Y/Y, and 3) what is the proper run rate for net management fee income going forward." ISI maintains its Buy rating on Taubman, which is currently trading at $77.73.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsISI
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!